Elias j. Anaissie - Nanotechnology

Author Information

Elias J. Anaissie is a prolific researcher with significant contributions to the field of hematologic diseases and infection prevention. His extensive body of work has had a substantial impact on both clinical practice and research. Although his current affiliation is not listed, his research has been widely recognized and cited, making him a prominent figure in his area of expertise.

Research Contributions

Elias J. Anaissie's research primarily focuses on infection prevention in patients with hematologic diseases, particularly multiple myeloma and acute leukemia. His work also delves into the effective management of invasive fungal diseases and antibiotic resistance in febrile neutropenia. Notable publications include guidelines for infection prevention in multiple myeloma and studies on the utilization and cost of cancer-related care in the US. He has also contributed to understanding the pharmacokinetics of drugs used in hematopoietic stem cell transplantation and the use of noninvasive tests to predict histologic activity in inflammatory bowel disease.

Aliases

Elias J. Anaissie is also known by several aliases including Elias J. Anaissie, E. J. Anaissie, E. Anaissie, Eli Anaissie, Elias J Anaissie, Elias Anaissie, E Anaissie, E J Anaissie, and Elias J. Anaissie.

Publication and Citation Metrics

Total Papers	453
Total Citations	43,468
h-index	105

Publications:

Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.

DOI: 10.1016/s2352-3026(21)00283-0

Year: 2022

Invasive Fusariosis in Patients with Hematologic Diseases

DOI: 10.3390/jof7100815

Year: 2021

Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis

DOI: 10.1186/s12913-021-07150-4

Year: 2021

Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease

DOI: 10.3748/wjg.v27.i9.866

Year: 2021

Time of catheter removal in candidemia and mortality.

DOI: 10.1016/j.bjid.2018.10.278

Year: 2018

Prevention of Infections in Patients with Hematological Malignancies

DOI: 10.1007/978-3-319-64263-5_49

Year: 2017

Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation

DOI: 10.1007/s40262-017-0581-x

Year: 2017

Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms

DOI: 10.1586/17474086.2015.1060576

Year: 2015

Distinguishing the Causes of Pulmonary Infiltrates in Patients With Acute Leukemia.

DOI: 10.1016/j.clml.2015.03.007

Year: 2015

How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach.

DOI: 10.1182/blood-2014-04-516211

Year: 2014

Can Nanotechnology Improve Metal Alloys?

What are the Benefits of Receiving a Scholarship or Award in Nanotechnology?

What are Platinum Catalysts?

What is Renal Clearance?

How is Soft Iron Utilized in Nanotechnology?

How Do You Start Learning Nanotechnology?

Are There Risks Associated with Nanotechnology in Resistance Development?

How Can One Assess Their Interpersonal Skills?

How Does Temperature Programmed Desorption Work?

What Makes the Gecko's Foot Special?

Partnered Content Networks

Relevant Topics